Literature DB >> 27091741

An evidence-based perspective on warfarin and the growing skeleton.

T Sugiyama1, Y Kono2, K Sekiguchi2, Y T Kim2, H Oda2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27091741     DOI： 10.1007/s00198-016-3588-5

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN： 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  15 in total

1.  Vitamin K antagonists' use and fracture risk: results from a systematic review and meta-analysis: comment.

Authors:  S S Zhao; Z Y Lin; Y Zhu
Journal:  J Thromb Haemost       Date:  2016-01-11       Impact factor: 5.824

2.  Bleeding and non-bleeding phenotypes in patients with GGCX gene mutations.

Authors:  Matthias Watzka; Christof Geisen; Monika Scheer; Regina Wieland; Verena Wiegering; Thomas Dörner; Hans-Jürgen Laws; Fatma Gümrük; Sahin Hanalioglu; Sule Unal; Davut Albayrak; Johannes Oldenburg
Journal:  Thromb Res       Date:  2014-07-12       Impact factor: 3.944

Review 3.  Vitamin K antagonists' use and fracture risk: results from a systematic review and meta-analysis.

Authors:  N Veronese; G Bano; G Bertozzo; S Granziera; M Solmi; E Manzato; G Sergi; A T Cohen; C U Correll
Journal:  J Thromb Haemost       Date:  2015-08-10       Impact factor: 5.824

Review 4.  Oral anticoagulant drugs and the risk of osteoporosis: new anticoagulants better than old?

Authors:  Antonella Tufano; Antonio Coppola; Paola Contaldi; Massimo Franchini; Giovanni Di Minno
Journal:  Semin Thromb Hemost       Date:  2015-02-19       Impact factor: 4.180

5.  Warfarin use and fracture risk: an evidence-based mechanistic insight.

Authors:  T Sugiyama; F Kugimiya; S Kono; Y T Kim; H Oda
Journal:  Osteoporos Int       Date:  2014-10-10       Impact factor: 4.507

6.  Does vitamin K2 play a role in the prevention and treatment of osteoporosis for postmenopausal women: a meta-analysis of randomized controlled trials.

Authors:  Z-B Huang; S-L Wan; Y-J Lu; L Ning; C Liu; S-W Fan
Journal:  Osteoporos Int       Date:  2014-12-17       Impact factor: 4.507

7.  Bone density in children with single ventricle physiology.

Authors:  Edgard A Bendaly; Linda A DiMeglio; William F Fadel; Roger A Hurwitz
Journal:  Pediatr Cardiol       Date:  2014-12-16       Impact factor: 1.655

8.  Atrial fibrillation, CHA2DS2-VASc score, antithrombotics and risk of non-traffic-, non-cancer-related bone fractures: A population-based cohort study.

Authors:  Hui-Chin Lai; Wu-Chien Chien; Chi-Hsiang Chung; Wen-Lieng Lee; Tsu-Juey Wu; Kuo-Yang Wang; Chia-Ning Liu; Tsun-Jui Liu
Journal:  Eur J Intern Med       Date:  2015-10-20       Impact factor: 4.487

9.  Timing of low bone mineral density and predictors of bone mineral density trajectory in children on long-term warfarin: a longitudinal study.

Authors:  M L Avila; E Pullenayegum; S Williams; A Shammas; J Stimec; E Sochett; K Marr; L R Brandão
Journal:  Osteoporos Int       Date:  2015-11-16       Impact factor: 4.507

10.  Association between use of warfarin with common sulfonylureas and serious hypoglycemic events: retrospective cohort analysis.

Authors:  John A Romley; Cynthia Gong; Anupam B Jena; Dana P Goldman; Bradley Williams; Anne Peters
Journal:  BMJ       Date:  2015-12-07
View more
  1 in total

1.  An evidence-based perspective on warfarin and the growing bone: response to Sugiyama et al.

Authors:  M L Avila; E Pullenayegum; A Shammas; L R Brandão
Journal:  Osteoporos Int       Date:  2016-04-18       Impact factor: 4.507
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.